Relay Therapeutics Inc. (RLAY) Social Stream
RELAY THERAPEUTICS INC (RLAY) Price Targets From Analysts
Use the tables below to see what analysts covering RELAY THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-10-11 | 5 | $66 | $51 | $57 | $9.32 | 511.59% |
2021-11-11 | 5 | $66 | $51 | $56.25 | $9.32 | 503.54% |
2021-11-12 | 5 | $66 | $47 | $55.25 | $9.32 | 492.81% |
2022-03-03 | 5 | $54 | $45 | $50 | $9.32 | 436.48% |
2022-05-06 | 5 | $54 | $45 | $48 | $9.32 | 415.02% |
2022-05-10 | 6 | $47 | $35 | $44 | $9.32 | 372.1% |
2022-05-24 | 6 | $47 | $35 | $43.666 | $9.32 | 368.52% |
2022-06-06 | 7 | $47 | $13 | $39.285 | $9.32 | 321.51% |
2022-08-05 | 7 | $47 | $13 | $38 | $9.32 | 307.73% |
2022-08-13 | 8 | $47 | $13 | $37.857 | $9.32 | 306.19% |
2022-09-02 | 8 | $47 | $13 | $38.125 | $9.32 | 309.07% |
2022-09-17 | 10 | $50 | $16 | $39.75 | $9.32 | 326.5% |
2022-09-30 | 10 | $50 | $16 | $37.888 | $9.32 | 306.52% |
2022-10-07 | 10 | $50 | $16 | $37.666 | $9.32 | 304.14% |
2022-11-07 | 10 | $50 | $16 | $37.444 | $9.32 | 301.76% |
2022-12-20 | 10 | $45 | $16 | $36.666 | $9.32 | 293.41% |
2023-01-27 | 10 | $45 | $16 | $35.555 | $9.32 | 281.49% |
2023-02-08 | 10 | $45 | $16 | $34.222 | $9.32 | 267.19% |
2023-02-24 | 10 | $45 | $16 | $33.555 | $9.32 | 260.03% |
2023-03-07 | 10 | $46 | $16 | $33.888 | $9.32 | 263.61% |
2023-03-09 | 10 | $46 | $16 | $33.3 | $9.32 | 257.3% |
2023-04-11 | 10 | $46 | $16 | $33 | $9.32 | 254.08% |
2023-04-18 | 11 | $46 | $16 | $32.636 | $9.32 | 250.17% |
2023-04-19 | 11 | $46 | $16 | $32.636 | $9.32 | 250.17% |
2023-05-04 | 11 | $46 | $12.5 | $30.045 | $9.32 | 222.37% |
2023-05-05 | 11 | $46 | $12.5 | $29.772 | $9.32 | 219.44% |
2023-06-06 | 10 | $46 | $12.5 | $28.15 | $9.32 | 202.04% |
2023-06-11 | 11 | $33 | $12.5 | $26.75 | $9.32 | 187.02% |
2023-08-09 | 11 | $33 | $12.5 | $25.954 | $9.32 | 178.48% |
2023-10-12 | 11 | $33 | $12.5 | $25.772 | $9.32 | 176.52% |
2023-10-13 | 11 | $33 | $9.4 | $25.49 | $9.32 | 173.5% |
2023-11-03 | 11 | $33 | $9.4 | $24.581 | $9.32 | 163.74% |
2023-11-09 | 12 | $33 | $9.4 | $23.309 | $9.32 | 150.1% |
The Trend in the Analyst Price Target
Over the past 36 months, RLAY's average price target has gone down $28.94.
RLAY reports an average of 146.99% for its upside potential over the past 46 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-03-07 | 10 | 46 | 16.0 | 33.888 | 17.59 | 92.65% |
2023-04-19 | 11 | 46 | 16.0 | 32.636 | 12.35 | 164.26% |
2023-05-04 | 11 | 46 | 12.5 | 30.045 | 11.22 | 167.78% |
2023-10-13 | 11 | 33 | 9.4 | 25.490 | 7.74 | 229.33% |
2023-10-18 | 11 | 33 | 9.4 | 25.036 | 7.08 | 253.62% |
RLAY Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.36 | 9 | 0 | 2 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 52 weeks, RLAY's average broker recommendation rating improved by 0.14.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- RELAY THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 3983.45% of all US stocks.
- In terms of how RELAY THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3050.74% of that group.
- RLAY has a greater number of analysts covering the stock than 2708.99% of stocks in the mid market cap category.
- RLAY has a greater average analyst price target than 2600.07% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, ALVR, KYMR, and CCCC are the three stocks most similar to RELAY THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is RLAY a Buy, Hold or Sell? See the POWR Ratings now!